Teishima, J. et al. 2024. Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma . Canadian Urological Association Journal. 18, 5 (Jan. 2024), E162–6. DOI:https://doi.org/10.5489/cuaj.8548.